title: The role of technology in clinical trials using stereotactic body radiotherapy.
abstract: Stereotactic body radiotherapy is a highly technology-driven treatment modality. The wider availability of in-room imaging and advanced radiotherapy delivery techniques has led to more institutions offering stereotactic ablative therapy (SABR). While some technological challenges remain, the crucial point for the next generation of SABR clinical trials is that today's technology is used correctly and close to its optimal potential for accuracy. The credentialing procedure of SABR needs to be extensive, but this investment will benefit the trial itself, the patients and the professionals involved.
authors.affiliation: 1 Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.|2 Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Marianne
authors.initials: M
authors.lastname: Aznar
authors.affiliation: 3 Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
authors.forename: Alejandra
authors.initials: A
authors.lastname: Méndez Romero
authors.affiliation: 3 Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
authors.forename: Ben J M
authors.initials: BJ
authors.lastname: Heijmen
mesh_terms: D020811:Biomedical Technology / Q000379:methods*; D002986:Clinical Trials as Topic; D006801:Humans; D016634:Radiosurgery / Q000295:instrumentation* / Q000379:methods* / Q000639:trends